Zhaoke Ophthalmology (06622) Announces Increase in Issued Shares and Confirms Public Float Compliance

Bulletin Express
03/03

Zhaoke Ophthalmology Limited (06622) released a monthly update for February 2026, reporting an authorized share capital of 1.60 trillion ordinary shares, each with a par value of USD 0.00000025, totaling USD 400,000. The issued share count rose from 547.97 million shares to 548.75 million shares, an increase of 0.78 million shares. The company confirmed that its public float remains above the required 25% threshold.

According to the filing, 779,000 new shares were issued during the month through the exercise of share options, generating HKD 621,434.25. No treasury shares or other convertible instruments were involved in the period. The update also notes official acknowledgement that all issued securities comply with relevant listing and regulatory requirements.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10